Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo
$0.0020 0.00 (0.00%)
As of 07/3/2025

About Acutus Medical Stock (NASDAQ:AFIB)

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
$0.00
$0.05
52-Week Range
$0.00
$0.22
Volume
N/A
Average Volume
33,047 shs
Market Capitalization
$59.56 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

AFIB Acutus Medical, Inc. - Seeking Alpha
Cold War Discovery Could Unlock $100 Trillion in Wealth
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical's stock was trading at $0.0550 at the start of the year. Since then, AFIB stock has decreased by 96.4% and is now trading at $0.0020.

Acutus Medical, Inc. (NASDAQ:AFIB) released its earnings results on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of ($0.92) by $0.02. The business had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%.

The following companies are subsidiaries of Acutus Medical: Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto (RIO).

Company Calendar

Last Earnings
11/11/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AFIB
Employees
340
Year Founded
2011

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%

Debt

Sales & Book Value

Annual Sales
$7.16 million
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-0.07

Miscellaneous

Free Float
28,228,000
Market Cap
$59.56 thousand
Optionable
Optionable
Beta
-0.34

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners